Диссертация (1141337), страница 22
Текст из файла (страница 22)
Vol. III. Interactions of Liposomes with the Biological Milieu.New York: Informa Healthcare USA, Inc., 2007. – P. 253-275.Evers B.M., Dilipkumar P., Townsend C.M. et al. Somatostatin andanalogs in the treatment of cancer.// What’s new in general surgery. 1989.Vol. 213(3). P.190-198.Feng Y, Huang T, Gao J, et al. Inhibition of metastatic progression ofSSTR2 gene transfection mediated by adenovirus in human pancreaticcarcinoma cells//J. J Huazhong Univ Sci Technolog Med Sci, 2006, 26(1):P.68-71.Florio T, Yao H, Carey KD, et al.
Somatostatin activation of mitogenactivated protein kinase via somatostatin receptor 1 (SSTR1)//J. MolEndocrinol, 1999, 13(1): P.24-37.Friedlander TW, Weinberg VK, Small EJ, et al. Effect of the somatostatinanalog octreotide acetate on circulating insulin-like growth factor-1 andrelated peptides in patients with non-metastatic castration-resistantprostate cancer: Results of a phase II study//J.
Urol Oncol, 2010, P.18732496.13858.59.60.61.62.63.64.65.66.67.68.69.70.Georgiadou M, Notas G, Xidakis C, et al. TNF receptors in Kupffer cells//J Recept Signal Transduct Res, 2011, 4(31): P.291-298.Gu J.M., Robinson J.R., Leung S.H. Binding of acrylic polymers tomucin/epithelial surface: Structure-property relationships.// Crit Rev TherDrug Carrier Syst. 1988. Vol.5. P.21-67.Guillermet GJ, Saint LN, Davenne L, et al. Novel synergistic mechanismfor sst2 somatostatin and TNFalpha receptors to induce apoptosis:crosstalk between NF-kappaB and JNK pathways// J.
Cell Death Differ,2007, 14(2): P.197-208.Hashimoto M., Takada K., Kiso Y. et al. Synthesis of palmitoylderivatives of insulin and their biological activities.// Pharm Res. 1989.Vol.6. P.171-176.Hayry P., Raisanen A., Ustinov J. et al. Somatostatin analog lanreotideinhibits myocyte replication and several growth factors in allograftarteriosclerosis./ Faseb J. 1993. Vol.
7. P.1055–1060.He Y, Yuan XM, Lei P, et al. The antiproliferative effects of somatostatinreceptor subtype 2 in breast cancer cells.// J. Acta Pharmacol Sin, 2009,30(7): P.1053-1059.Held-Feindt J, Forstreuter F, Pufe T, et al. Influence of the somatostatinreceptor sst2 on growth factor signal cascades in human glioma cells.// J.Brain Res Mol Brain Res, 2001, 87(1): P.12-21.Hierowski M.T., Liebow C., du Sapin K. et al. Stimulation bysomatostatin of dephospharylation of membrane proteins in pancreaticcancer MIA PaCa-2 cell line.// FEBS Lett. 1985. Vol.179. P.252-256 .Hillgren A., Lindgren J., Alden M. Protection mechanism of Tween 80during freeze-thawing of a model protein, LDH.// Int J Pharm.
2002.Vol.237. P.57-69.Hirai S., Yashiki T., Matsuzawa T. et al. Absorption of drugs from thenasal mucosa of rat./ Int J Pharm. 1981. Vol.7. P.317-325 .Ho N.F.H., Day J.S., Barsuhn C.L. et al. Biophysical model approaches tomechanistic transepithelial studies of peptides./ /J Control Release. 1990.Vol.11. P.3-2.Hobart P., Crawford R., Shen L. et al. Cloning and sequence analysis ofcDNAs encoding two disting somatostatin precursor found in theendocrine pancreas of angleship./ Nature. 1980. Vol.288. P.137-141.Hotz M.A., Gong J., Traganos F.
еt al. Flow cytometric detection ofapoptosis: comparison of the assays of in situ DNA degradation andchromatin changes.// Cytometry. 1994. V. 15. № 3. P.237 – 244.13971.72.73.74.75.76.77.78.79.80.81.Hutton D.A., Pearson J.P., Allen A. et al. Mucolysis of the colonic mucusbarrier by faecal proteinases: Inhibition by interacting polyacrylate.//ClinSci. 1990. Vol.78.
P.265- 27.Ishii A, Imanishi Y, Kobayashi K, et al. The levels of somatostatinreceptors in causative tumors of oncogenic osteomalacia are insufficientfor their agonist to normalize serum phosphate levels.//J. Calcif Tissue Int,2010, 86(6): P.455-462.Jia W D, Zhang C H, Xu G L, et al. Octreotide therapy for hepatocellularcarcinoma: a systematic review of the evidence from randomizedcontrolled trials. //Hepatogastroenterology, 2010, 57: P.292-299.Kenworthy A.K., Hristova K., Needham D., McIntosh T.J.
Range andmagnitude of the steric pressure between bilayers containingphospholipids with covalently attached poly(ethylene glycol) // Biophys J.– 1995.– Vol.68, №5. – Р. 1921–1936.Keri G., Erchegyi J., Horvath A. et al. A tumor-selective somatostatinanalog (TT-232) with strong in vitro and in vivo antitumor activity.//ProcNatl Acad Sci USA. 1996. Vol. 93. P.12513–12518.Kidd M, Drozdov I, Joseph R, etal. Diferential cytotoxicity of novelsomatostatin and dopamine chimeric compounds on bronchopulmonaryand small intestinal neuroendocrine tumor cell lines.// Cancer, 2008,113:P.690-700.Kuriyama I, Miyazaki A, Tsuda Y.
Inhibitory effect of somatostatinPeptide analogues on DNA polymerase activity and human cancer cellproliferation// J. Anticancer Res, 2010, 30(12):P. 4841-4849.Lai H S, Chen Y. Efect of octritide on post operative intraperitonealadhesion in rats.// Scand J Gastroenterol, 1996;31:P.678-681.Laklai H, Laval S, Dumartin L, et al. Thrombospondin-1 is a criticaleffector of oncosuppressive activity of sst2 somatostatin receptor onpancreatic cancer.// J. Proc Natl Acad Sci USA, 2009, 10(42): P.1776917774.Lamberts S.W.J., Reubi J.C., Uiterlinden P. et al.
Studies on themechanism of action of the inhibitory effect of somatostatin analog SMS201-995 on the growth of the prolactin/adrenocorticotropin –secretingpituitary tumour 7315a.// Endocrinology. 1986. Vol.118. P.2188-2194.Laukkanen ML1, Alfthan K, Keinänen K. Functional immunoliposomesharboring a biosynthetically lipid-tagged single-chain antibody. //Biochemistry. 1994 Sep 27;33(38):P.11664-70.14082.83.84.85.86.87.88.89.90.91.92.93.Lee R.J, Low P.S.Li M, Wang XC, Li W, et al.
Somatostatin receptor-1induces cell cycle arrest and inhibits tumor growth in pancreatic cancer// J.Cancer Sci, 2008, 99(11): P.2218-2223.Liebow C., Hierowski M.T., du Sapin K. Hormonal control of pancreaticcancer growth.//Pancreas. 1986. Vol. 1. P.44-48.Liu Y. , Wang X. , Wei J. , et al . The synergistic effect of octreotide onnon-small eell lung eaneer inhibited by paclitaxel.// Chin J CancerBiother , 2008, 15(3): P.210-216.Liu Y.，Kuang S.，Huang X. , et al . The study on expression of growthfactor of vascular endothelial cells in hepatocellular carcinoma wasinhibited by somatostatin analogue.// J South Med Univ.
2008, 28(9):P.1677-1678.Liu ZR, Qin RY, Wu GS. Effect of octreotide on human pancreatic cancercells after transfected with somatostatin receptor type 2 gene.// J. World JGastroenterol, 2004, 10(1-5): P.2292-2294.Ludvigsen E, Stridsberg M, Taylor JE, et al. Subtype selectiveinteractions of somatostatin and somatostatin analogs with SST1, SST2,and SST5 in BON-1 cells. // J. Med Oncol, 2004, 21(3):P. 285-295.Manoj K, Liu Z. , Tian R. , et al. Growth inhibition receptor 2 genetransfection inhibited the growth mechanism of pancreatic tumor cells //Chinese Medical Journal , 2004, 84(9): P.760-765.Massa A, Barbieri F, Aiello C, et al.
The phosphotyrosine phosphatase etamediates somatostatin inhibition of glioma proliferation via thedephosphorylation of ERK1/2[J]. Ann N Y Acad Sci, 2004, 1030: P.264274.Mazziotti G., Floriani I., Bonadonna S.,etal.Efects of SomatostatinAnalogson Glucose Homeostasis: A Metaanalysis of AcromegalyStudies.// J.Clin.Endocrinol.Metab, 2009, 94:P.1500-1508.Miyajima K. Role of saccharides for the freeze–thawing and freeze dryingof liposome // Adv. Drug Deliv. Rev. – 1997.
– Vol. 24, № 2-3. – P. 151–159.Nikolopoulou V N, Thomopoulos K C, Katsakoulis E C, etal. The efect ofoctreotide as an adjunct treatment in active non variceal uppergastrointestinal bleeding. //J Clin Gastroenterol, 2004, 38: P.243-247.Oberg K. State of the art and future prospects in the management ofneuroendocrine tumors.// J. The quarterly journal of nuclear medicine :official publication of the Italian Association of Nuclear Medicine (AIMN)14194.95.96.97.98.99.100.101.102.[and] the International Association of Radiopharmacology (IAR), 2000,44(1):P.3-12.Ohtake S., Schebor C., Palecek S.P. et al. Phase behavior of freeze-driedphospholipid–cholesterol mixtures stabilized with trehalose // Biochim.Biophys. Acta.
– 2005. –Vol. 1713, № 1. – P. 57-64.Pagès P, Benali N, Saint-Laurent N, et al. Sst2 somatostatin receptormediates cell cycle arrest and induction of p27(Kip1) Evidence for therole of SHP-1// J Biol Chem, 1999, 274(21): P.15186-15193.Park J W, Hong K, Carter P, et al. Development of anti-p185HER2immunoliposomes for cancer therapy.//J. Proceedings of the NationalAcademy of Sciences of the United States of America, 1995,92(5):P.1327-31.Qin Y. , Li J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
